These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 30255238

  • 1. Immunoglobulin A nephropathy secondary to Wilson's disease: a case report and literature review.
    Shimamura Y, Maeda T, Gocho Y, Ogawa Y, Tsuji K, Takizawa H.
    CEN Case Rep; 2019 Feb; 8(1):61-66. PubMed ID: 30255238
    [Abstract] [Full Text] [Related]

  • 2. Practical recommendations and new therapies for Wilson's disease.
    Brewer GJ.
    Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
    [Abstract] [Full Text] [Related]

  • 3. [Wilson's disease with severe neurological manifestations: response to trientine plus zinc therapy].
    Serra B, Primo J, García M, Amorós I, Aragó M, Merino C.
    Gastroenterol Hepatol; 2004 May; 27(5):307-10. PubMed ID: 15117609
    [Abstract] [Full Text] [Related]

  • 4. IgA Nephropathy with Wilson's Disease: A Case Report and Literature Review.
    Bhandari G, Tiwari V, Gupta A, Gupta P, Bhargava V, Malik M, Gupta A, Bhalla AK, Rana DS.
    Indian J Nephrol; 2021 May; 31(5):474-477. PubMed ID: 34880558
    [Abstract] [Full Text] [Related]

  • 5. Recognition and treatment of neurologic Wilson's disease.
    Lorincz MT.
    Semin Neurol; 2012 Nov; 32(5):538-43. PubMed ID: 23677665
    [Abstract] [Full Text] [Related]

  • 6. [Magnetic Resonance Imaging Improvement in a Patient with Wilson's Disease Following Treatment with Trientine Hydrochloride and Zinc Acetate].
    Kim Y, Koide R, Kawata A.
    Brain Nerve; 2015 May; 67(5):635-8. PubMed ID: 25957210
    [Abstract] [Full Text] [Related]

  • 7. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study.
    Merle U, Schaefer M, Ferenci P, Stremmel W.
    Gut; 2007 Jan; 56(1):115-20. PubMed ID: 16709660
    [Abstract] [Full Text] [Related]

  • 8. Dense Kayser-Fleischer ring in asymptomatic Wilson's disease (hepatolenticular degeneration).
    Sullivan CA, Chopdar A, Shun-Shin GA.
    Br J Ophthalmol; 2002 Jan; 86(1):114. PubMed ID: 11801516
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of renal damage in Wilson's disease-Detailed analysis of 20 Chinese cases.
    Jin S, Sun Z, Fang X, Yang W.
    Med Clin (Barc); 2024 Oct 18; 163(7):360-366. PubMed ID: 38890098
    [Abstract] [Full Text] [Related]

  • 10. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T, Tirouche YD, Abaoub-Germain A, Theodore F.
    Encephale; 2007 Dec 18; 33(6):924-32. PubMed ID: 18789784
    [Abstract] [Full Text] [Related]

  • 11. Wilson's disease with hepatic presentation in childhood.
    Karim MB, Rahman MM, Islam MS.
    Mymensingh Med J; 2007 Jan 18; 16(1):29-32. PubMed ID: 17344776
    [Abstract] [Full Text] [Related]

  • 12. Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment.
    Brewer GJ.
    CNS Drugs; 2005 Jan 18; 19(3):185-92. PubMed ID: 15740174
    [Abstract] [Full Text] [Related]

  • 13. Wilson's disease with cognitive impairment and without extrapyramidal signs: improvement of neuropsychological performance and reduction of MRI abnormalities with trientine treatment.
    Chung EJ, Kim EG, Kim SJ, Ji KH, Seo JH.
    Neurocase; 2016 Jan 18; 22(1):40-4. PubMed ID: 25988284
    [Abstract] [Full Text] [Related]

  • 14. Atypical case of Wilson's disease with psychotic onset, low 24 hour urine copper and the absence of Kayser-Fleischer rings.
    Krstić D, Antonijević J, Špirić Ž.
    Vojnosanit Pregl; 2014 Dec 18; 71(12):1155-8. PubMed ID: 25639007
    [Abstract] [Full Text] [Related]

  • 15. The treatment of Wilson's disease, a rare genetic disorder of copper metabolism.
    Purchase R.
    Sci Prog; 2013 Dec 18; 96(Pt 1):19-32. PubMed ID: 23738435
    [Abstract] [Full Text] [Related]

  • 16. Treatment of Wilson's disease with zinc: XV long-term follow-up studies.
    Brewer GJ, Dick RD, Johnson VD, Brunberg JA, Kluin KJ, Fink JK.
    J Lab Clin Med; 1998 Oct 18; 132(4):264-78. PubMed ID: 9794697
    [Abstract] [Full Text] [Related]

  • 17. Pathophysiology and treatment of Wilson's disease.
    Tankanow RM.
    Clin Pharm; 1991 Nov 18; 10(11):839-49. PubMed ID: 1794220
    [Abstract] [Full Text] [Related]

  • 18. Late-onset Wilson's disease with neurological involvement in the absence of Kayser-Fleischer rings.
    Ross ME, Jacobson IM, Dienstag JL, Martin JB.
    Ann Neurol; 1985 Apr 18; 17(4):411-3. PubMed ID: 4004163
    [Abstract] [Full Text] [Related]

  • 19. Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation?
    Schilsky ML.
    Curr Gastroenterol Rep; 2001 Feb 18; 3(1):54-9. PubMed ID: 11177695
    [Abstract] [Full Text] [Related]

  • 20. Trientine-induced neurological deterioration in a patient with Wilson's disease.
    Kim B, Chung SJ, Shin HW.
    J Clin Neurosci; 2013 Apr 18; 20(4):606-8. PubMed ID: 23274038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.